LQT Therapeutics
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $19M
Investors
- 5
About LQT Therapeutics
LQT Therapeutics, Inc.Founded in 2014 and headquartered in Laval, Canada, LQT Therapeutics, Inc. specializes in precision medicine targeting serious cardiac conditions.LQT Therapeutics develops precision medicine solutions aimed at addressing serious cardiac conditions, notably Long QT Syndrome (LQTS), atrial fibrillation, and heart failure. The company's primary focus is on selective inhibitors of Serum Glucocorticoid Inducible Kinase (SGK1) designed to enhance cardiac electrical activity and contractility.LQT Therapeutics generates revenue through partnerships and collaborations with healthcare institutions and research organizations. The company engages in B2B transactions, providing its SGK1 inhibitors to clinical trial participants as part of ongoing studies. The revenue model includes fees for research and development services, along with potential licensing agreements from successful product outcomes.00 mn in August 2021, LQT Therapeutics plans to expand its portfolio of SGK1 inhibitors through phase 1 human clinical studies. The company aims to develop new products targeting serious cardiac conditions, with specific timelines for these developments not disclosed.
Who invested in LQT Therapeutics
5 investors across 1 round
See all investors in LQT Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 10, 2021
Amount
$19M
Investors
Questions about LQT Therapeutics
Who invested in LQT Therapeutics?
LQT Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LQT Therapeutics raised?
LQT Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LQT Therapeutics last raise money?
LQT Therapeutics's most recent round on record is a Series A, in Aug 2021.
What does LQT Therapeutics do?
LQT Therapeutics is a biotechnology company.
Where is LQT Therapeutics headquartered?
LQT Therapeutics is headquartered in Laval, Canada.
Which VCs invest in companies like LQT Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at LQT Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like LQT Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.